John L. Higgins
2014
In 2014, John L. Higgins earned a total compensation of $6M as Chief Executive Officer at Ligand Pharmaceuticals, a 101% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $383,097 |
|---|---|
| Option Awards | $4,552,951 |
| Salary | $510,198 |
| Stock Awards | $595,360 |
| Other | $5,650 |
| Total | $6,047,256 |
Higgins received $4.6M in option awards, accounting for 75% of the total pay in 2014.
Higgins also received $383.1K in non-equity incentive plan, $510.2K in salary, $595.4K in stock awards and $5.7K in other compensation.
Rankings
In 2014, John L. Higgins' compensation ranked 1,189th out of 13,032 executives tracked by ExecPay. In other words, Higgins earned more than 90.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,189 out of 13,032 | 91st |
Division Manufacturing | 438 out of 4,966 | 91st |
Major group Chemicals And Allied Products | 142 out of 1,686 | 92nd |
Industry group Drugs | 112 out of 1,365 | 92nd |
Industry Pharmaceutical Preparations | 100 out of 1,043 | 90th |
Source: SEC filing on April 14, 2017.
Higgins' colleagues
We found four more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2014.